Dr. Caryn Lerman was recently appointed Deputy Director of the Abramson Cancer Center at the University of Pennsylvania's School of Medicine.
Dr. Lerman is the Mary W. Calkins Professor in the Department of Psychiatry, with a secondary appointment the Annenberg School. She is the Director of the NIH-funded Transdisciplinary Tobacco Use Research Center at the University of Pennsylvania and is Principal Investigator for studies examining the role of genetic factors in response to pharmacotherapy for smoking cessation. Dr. Lerman is also Co-Director of the Center of Excellence in Cancer Communication Research and Principal Investigator for studies to evaluate anti-tobacco PSAs.
Dr. Lerman is a former member of the National Cancer Institute (NCI) Board of Scientific Advisors and the National Human Genome Research Institute Advisory Panel on the ELSI (Ethical, Legal, and Social Implications) Program. She has been the recipient of the Society of Behavioral Medicine New Investigator Award (1989), the American Psychological Association Award for Outstanding Contributions to Health Psychology (1995), and the Joseph Cullen Award for Tobacco Research from the American Society of Preventative Oncology (2004). Recently, she co-chaired the NCI Tobacco Research Implementation Group that produced recommendations for tobacco research priorities for the next 5-10 years. She has published more than 185 articles in peer-reviewed journals.